The next big catalyst for Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) is just around the corner.
Investors are watching closely for the long-awaited feasibility study on its Bilboes project, which Panmure Liberum believes could reshape the outlook for the Zimbabwe-focused gold miner.
A positive outcome could lower upfront capital costs and boost returns, particularly if Caledonia opts for a scaled-back development based on producing concentrate rather than full in-country processing.
Unlocking value
The update, expected in the coming months, could unlock significant shareholder value.
A concentrate-only option would cut execution risk and avoid the need for BIOX processing, a complex and costly technique for refractory ore.
Panmure notes that global demand for precious metals concentrate is currently strong, meaning the trade-offs, including slightly lower payability and increased transport costs, may be worth it.
In the meantime, Caledonia has delivered a solid first quarter, with earnings (EBITDA) more than doubling year on year to $22.6 million.
The Blanket mine produced a Q1 record of 18,671 ounces, despite seasonal rainfall and operational slowdowns over the Christmas and Easter period.
Add in a further 435 ounces from early stage production at Bilboes, and revenue hit $56.2 million, up 46% on the year. Cash costs per ounce were higher than hoped at $1,202, but the company has reaffirmed its full-year cost guidance, suggesting improvement ahead.
Cash cushion
Importantly, net cash from operations jumped to $13.3 million, helping to move the company into a net cash position of $18.6 million, a turnaround from the $14.2 million net debt recorded a year ago.
Panmure expects strong free cash flow to continue, supported by a 2025 production target of up to 78,000 ounces and a healthy gold price backdrop.
The current valuation looks undemanding, with the stock trading on just 1.8 times expected EBITDA.
Panmure keeps its 'buy' rating and 2,054p target price unchanged, confident that the shares have room to run as production builds, cash flow improves and Bilboes de-risking progresses.
The shares were steady at 1,015p.